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ABSTRACT Given the importance of protein aggregation in amyloid diseases and in the manufacture of protein pharmaceuti-
cals, there has been increased interest in measuring and modeling the kinetics of protein aggregation. Several groups have
analyzed aggregation data quantitatively, typically measuring aggregation kinetics by following the loss of protein monomer
over time and invoking a nucleated growth mechanism. Such analysis has led to mechanistic conclusions about the size and
nature of the nucleus, the aggregation pathway, and/or the physicochemical properties of aggregation-prone proteins. We
have examined some of the difﬁculties that arise when extracting mechanistic meaning from monomer-loss kinetic data. Using
literature data on the aggregation of polyglutamine, a mutant b-clam protein, and protein L, we determined parameter values for
18 different kinetic models. We developed a statistical model discrimination method to analyze protein aggregation data in light of
competing mechanisms; a key feature of the method is that it penalizes overparameterization. We show that, for typical mono-
mer-loss kinetic data, multiple models provide equivalent ﬁts, making mechanistic determination impossible. We also deﬁne the
type and quality of experimental data needed to make more deﬁnitive conclusions about the mechanism of aggregation. Specif-
ically, we demonstrate how direct measurement of ﬁbril size provides robust discrimination.INTRODUCTION
Protein aggregation has been linked to a number of degener-
ative amyloid diseases, such as Alzheimer’s, Huntington’s,
and the prion-related diseases. In these diseases, the mature
aggregated species is typically b-sheet and fibrillar in
morphology (1). Aggregation also poses problems of conse-
quence in the manufacture of protein therapeutics: it can
occur during purification, formulation, packaging, or storing
of recombinant proteins and can lead to lowered yields,
reduced efficacy, altered pharmacokinetic profiles, and
potentially life-threatening immunological responses (2,3).
The growing awareness of the importance of protein mis-
folding and aggregation has led to a concomitant increased
interest in measuring and modeling the kinetics of protein
aggregation.
In evaluating kinetic data on the aggregation of proteins
and peptides, particularly with fibrillogenesis, some kind of
nucleated growth mechanism has generally been invoked.
Conventionally, the term ‘‘nucleation’’ has been used to
indicate a localized phase transition, but the word has been
appropriated to describe the onset of fibril growth. Descrip-
tions and definitions vary, but generally, nucleated growth is
considered to be characterized by 1), a sigmoidal growth
curve with lag, propagation, and plateau phases; 2), a reduc-
tion in lag time with the addition of ‘‘seeds’’; and, some-
times, 3), a critical concentration below which aggregation
will not occur (4–6). Sophisticated mathematical models
have been developed that describe protein aggregation
kinetics (e.g., (7–10)). However, application of these models
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to both the nature of the available experimental data and the
complexity of the mathematical models. Despite these diffi-
culties, several groups have analyzed monomer-loss kinetic
data quantitatively using simplified kinetic models. It is
important to note that such analysis has led to conclusions
about the nature of the aggregation nucleus, the dominant
pathway of aggregation, and/or the physicochemical proper-
ties of proteins that undergo aggregation.
Ferrone proposed that a simple algebraic equation
describes monomer-loss kinetics adequately under some
limiting conditions (11); in particular, only data at early
time points (~10–20% of total monomer loss) is included.
Wetzel and co-workers used this approach to analyze the
aggregation of polyglutamine peptides, concluding that the
aggregation nucleus is a structured monomer in equilibrium
with the bulk pool of disordered monomers and that the equi-
librium constant, though small, increases with increasing
polyglutamine chain length (12–14). The same approach
was used in studies of the aggregation kinetics of ataxin-3
(15) and b-clam proteins (16), and a similar conclusion, of
an energetically unfavorable monomeric nucleus at equilib-
rium with the bulk unstructured monomer, was reached.
Using a similar analysis, aggregation of protein L was deter-
mined to proceed via equilibrated nuclei that were dimers
and/or trimers (17).
Other groups have applied a similar mechanistic scheme,
but with different methods for fitting the model to the data.
One method involves plotting the log of a specific time
(lag time or t50) versus the log of concentration, in which
case the slope is equated to either n/2, or (n þ 1)/2, where
n is the size of the nucleus. This method was used in a study
doi: 10.1016/j.bpj.2008.12.3903
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nuclei are hexamers but Sup35pNM nuclei are trimers (18).
Morris et al. argue for a different scheme: an autocatalytic
mechanism, in which a slow but irreversible nucleation step
is followed by further nucleation catalyzed by the reaction
product (19). They derived a two-parameter analytical solu-
tion to the differential rate equations describing this mecha-
nism, and used this model to fit kinetic rate constants to
several sets of data in the literature. It is of interest that
one data set came from Chen et al. (13), who had fit the
data to the Ferrone approximation for nucleated polymeriza-
tion. In all cases, reasonably good fits of the data to the
model equation were obtained. Unlike the Ferrone approxi-
mation, data over the entire range of monomer loss was
used in the model fitting; however, the fitted data were at
only a single concentration. The autocatalytic model has
been used by others, for example, in an analysis of insulin
aggregation (20).
Somewhat more complex models have been used by a few
groups. For example, a three-step mechanism that included
monomer activation, nucleation, and elongation was
proposed to explain FtsZ protein assembly (21). Experi-
mental data were fit to a six-parameter model, and the result-
ing excellent fit was used to argue that FtsZ assembly is
cooperative and proceeds via a dimeric nucleus. In another
example, a fibril fragmentation step was added to a model
of Sup35 aggregation (22), and the additional parameters
improved model fit. In a third study, both homogeneous
and heterogeneous nucleation steps, as well as fibril elonga-
tion by monomer addition, were included in the analysis of
aggregation data of islet amyloid polypeptide (IAPP) (23).
In other cases, researchers have fit data to empirical
equations in the absence of a specific mechanistic scheme.
For example, Dubay et al. (24) collected literature data on
a variety of proteins and, neglecting both the lag and plateau
phases, fit the data to a simple exponential equation to extract
a single rate constant; this parameter was then used to corre-
late to a variety of physical properties, such as hydropho-
bicity and charge. A similar approach was taken in an
examination of the effect of mutations on acylphosphatase
aggregation (25,26). Other researchers have also used expo-
nential decay curves to fit aggregation data, and in some
cases have related the exponent to a lumped kinetic param-
eter (27,28). The logistic and Gompertz functions have
been used widely to model sigmoidal curves; examples in
which these equations (or variations) were applied to protein
aggregation kinetics include an examination of the effect of
solution conditions on insulin aggregation (29), an investiga-
tion of aggregation of microtuble-associated protein tau (30),
and studies on the effects of mutations on aggregation of
glucagon (31) and IAPP (32).
In this work, we examined some of the issues that arise
when fitting model equations to experimental data of protein
aggregation kinetics, highlighting the difficulty in extracting
mechanistic meaning from such modeling analyses. WeBiophysical Journal 96(7) 2871–2887focused primarily on fibril growth kinetics because of their
importance in amyloid disease. First, we derived several
kinetic models that describe competing aggregation schemes.
We next created a ‘‘test’’ monomer-loss data set and fitted
parameters for each of the models to the data using nonlinear
regression. Since reasonable parameter values were obtained
for several different models, we developed a statistical model
discrimination method to compare the kinetic models. A key
feature of this method is that the model rankings are weighted
by the number of regressed parameters, effectively penalizing
overparameterized models. We demonstrated that multiple
models derived from disparate aggregation mechanisms
provided equivalent fits. We conclude, therefore, that it is
generally not possible to elucidate a mechanism of protein
aggregation simply from analysis of monomer-loss kinetic
data. We then defined the type and quality of experimental
data needed to make definitive conclusions about the mecha-
nism of aggregation. Finally, we examined the effect of
‘‘seeding’’ on monomer-loss kinetics to investigate the utility
of seeding experiments in distinguishing among particular
mechanisms of aggregation.
MATERIALS AND METHODS
Parameter regression
Model parameters were regressed using Athena Visual Studio 12.0 (Athena
Visual Software, Naperville, IL), except where indicated. Athena Visual
Studio provides a Windows-based interface for inputs into equation solving
and parameter estimation programs. It employs an implicit integrator
package, DDAPLUS, for solving initial-boundary value problems described
by sets of mixed differential and algebraic equations (DDAPLUS is an
extension of the DASSL predictor-corrector algorithm and is described in
detail elsewhere (33,34)). Parameter estimation from multiresponse data is
provided by nonlinear least-squares regression (sum-of-squares minimiza-
tion) using the GREGPLUS algorithm described elsewhere (34,35); confi-
dence limits on parameters are calculated from the covariance matrix. Sets
of monomer-loss data at each initial concentration were considered indepen-
dent responses. The modeling equations and monomer-loss kinetic data were
programmed into Athena Visual Studio, along with initial guesses for the
parameter values. The modeling equations were numerically integrated
and the best-fit parameters and 95% confidence intervals were determined
via least-squares regression.
Model discrimination
A statistically valid model discrimination procedure for multiresponse data
was implemented according to the method described by Stewart et al.
(36). All models were assigned equal prior probability, and the posterior
probability, PðmjjY¼Þ, of model mj, given the monomer-loss data matrix Y,
was calculated via
P

mjjY¼

f2pj=2j v
¼ j
jve=2
vik ¼
P
u

Yiu  GjiðuÞ

Yku  GjkðuÞ
 ; (1)
where u is the vector of times at which the data were taken, pj is the number
of regressed parameters in model mj, ve is the degrees of freedom, and Gji is
the solution for response i of model mj. ve is calculated as the total number of
data points (including replicates) minus the number of time points at which
data were taken; if a set of monomer-loss data did not include replicates,
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FIGURE 1 Schematics illustrating aggregation models.
Open symbols indicate various conformations of monomer.
Solid symbols indicate aggregates classified as fibrillar. (a)
Preequilibrated nucleus. (b) Slow initiation. (c) Monomer
partitioning. (d) Autocatalytic. (e) Sequential growth. (f)
Qualitative Gibbs (free) energy sketches for PN and SI
mechanisms. The dagger indicates a transition state. The
sketch illustrates that in the PN mechanism, N exists as
a (meta)stable species at a local energy minima; this species
is absent in the SI mechanism.ve was set equal to 1. The matrix vj is the covariance matrix, containing the
products of the residual errors at each time point. The covariance matrix
cannot have any missing values, so the data sets must be full; in other words,
data must be obtained at all time points for each initial concentration. The
2pj/2 term is obtained during the derivation of Eq. 1 (36). This term penal-
izes those models with a greater number of parameters, thereby offsetting the
improvement in the fit of a model due to overparameterization. Thus, an
increase in the number of parameters must be statistically justifiable to
improve the posterior probability of the model. The posterior probabilities
were normalized to give the posterior probability share pj:
pj ¼
P

mjjY¼

P
k
PðmkjY¼Þ
: (2)
In essence, pj reports on the relative likelihood that model mj provides the
best fit of the data. The numerical integration of the modeling equations
and other calculations were completed using Mathematica 6.0 (Wolfram
Research, Champaign, IL).
RESULTS
Mathematical models of monomer-loss kinetics
Starting with several commonly invoked mechanisms for
fibril formation kinetics, we derived models describing mono-
mer-loss and fibril-growth kinetics. We restricted our study to
relatively simple models, with no more than three parameters.
Qualitative descriptions or illustrations of aggregation
processes will be referred to as ‘‘schematics’’, the sequence
of steps describing the aggregation process will be referred
to as the ‘‘reaction pathway’’, the system of differential equa-
tions derived from the reaction pathway will be referred to as
the ‘‘modeling equations’’, and the numerical solution to the
modeling equations will be referred to as the ‘‘model solu-
tion’’. Note that none of the reaction pathways contain true
chemical reactions, in that no covalent bonds are created or
broken. The schematic of each model is illustrated in Fig. 1.Preequilibrated nucleus (PN) model
In the PN schematic, monomers (M) are in rapid equilibrium
with a nucleus (N) containing n monomers, characterized by
an equilibrium constant KPN ¼ [N]/[M]n. Thus, the PN sche-
matic posits that the nucleus exists as an identifiable species,
and that the rate for interconversion between nM and N is
much faster than that of subsequent steps. Typically, one
assumes that KPN << 1, because the nucleus is energetically
unfavorable relative to the bulk monomer, but this is not
a requirement of the mathematical formulation. Fig. 1 f
contains a free-energy diagram that qualitatively demonstrates
these concepts. Free M binds irreversibly to N to form fibril
Fnþ1, with the rate of formation described by the rate constant
k1PN. Fibrils grow by continued addition of M to Fx, where x
indicates the number of monomers in the fibril and xR nþ 1.
The rate of growth is described by k2PN, which is assumed to
be independent of x. Thus, the PN reaction pathway is
nM4
KPN
N
M þ N/k1PN Fnþ1
M þ Fx/k2PN Fxþ 1; xRn þ 1
We set [N] ¼ KPN[M]n and ½F ¼
PN
i¼nþ1
½Fi, yielding the PN
modeling equations
d½M
dt
¼ k1PN½Mnþ 1k2PN½M½F
d½F
dt
¼ k
1PN
½Mnþ 1
; (3)
where k1PN ¼ k1PNKPN. From Eq. 3 we note that monomer-
loss kinetic data cannot be used to find k1PN and KPNBiophysical Journal 96(7) 2871–2887
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solved by numerical integration given initial conditions that
[M] ¼ [M]0 and [F] ¼ 0 at t ¼ 0. (The assumption that [F] ¼
0 at t¼ 0 is relaxed later when simulating seeding experiments.)
Ferrone approximation (FA) of the PN model
Ferrone et al. (11,13) derived a simple algebraic equation to
describe the PN model monomer-loss kinetics, subject to two
simplifying assumptions. First, if data are restricted to very
early times, then [M] z [M]0. Second, if monomer loss by
addition to fibrils exceeds monomer loss by nucleation,
then k1PN½Mnþ1 << k2PN½M ½F . Application of these
approximations leads to an analytic solution to Eq. 3 of
½M ¼ ½M0
k1PNk2PN
2
½Mnþ 20 t2 ¼ ½M0
k1FA
2
½Mnþ 20 t2;
(4)
where k1FA ¼ k1PNk2PN ¼ k1PNKPNk2PN. Using these
approximations, the fibril growth kinetics are
½F ¼ k1PN½Mnþ 20 t: (5)
Chen et al. developed a graphical method for analyzing
monomer-loss kinetic data using the FA model (13). Per
Eq. 4, a plot of [M] versus t2 is linear, with slope
0:5k1FA½Mnþ20 . If data are taken at multiple initial concen-
trations, one can then plot the log(slope) versus log[M]0.
The slope of this log-log plot is nþ2, and the intercept is
log(0:5k1FA).
Slow initiation (SI) model
The SI reaction pathway consists of two irreversible steps:
1), n monomers converting to a fibril, Fn, with a rate constant
k1SI; and 2), M adding to Fx with a rate constant k2SI.
nM/
k1SI
Fn
M þ Fx/
k2SI
Fxþ1; xRn:
In the SI reaction pathway, the first reaction is typically
considered to be slow relative to the second, but this is not
a requirement of our mathematical formulation. The SI model
differs from the PN model in that there is no assumption of
a metastable nucleus in the former. A free-energy diagram
is shown in Fig. 1 f that illustrates the SI model, assuming
that the first reaction is slow and has a high activation energy.
This first reaction step has sometimes been called nucleation
by others, and the transition state (highest point on the free-
energy diagram) has sometimes been called a nucleus. We
do not use that terminology, instead reserving ‘‘nucleus’’
for the metastable species described in the PN model. Similar
to the PN model, the fibril-growth rate constant k2SI is
assumed to be independent of fibril size and ½F ¼ PN
i¼n
½Fi.
The SI modeling equations are readily derived:Biophysical Journal 96(7) 2871–2887d½M
dt
¼ nk1SI½Mnk2SI½M½F
d½F
dt
¼ k1SI½Mn :
(6)
This set of coupled differential equations was solved by
numerical integration.
Autocatalytic (AC) model
In the AC reaction pathway, monomer M irreversibly
converts to F1 with a rate constant of k1AC. F1 then catalyzes
the formation of additional F1 from M with a rate constant of
k2AC:
M/
k1AC
F1
M þ F1/
k2AC
F1 þ F1:
Unlike the PN and SI reaction pathways, the AC reaction
pathway does not include a step for monomer loss by addi-
tion to Fx. Rather, fibrils are postulated to grow by coales-
cence of Fx, with xR 1. Because these modeling equations
will be applied to monomer-loss kinetic data, fibril coales-
cence steps are not necessary in our formulation. In the
AC model, one implicitly assumes that each monomer in
a fibril retains its ability to catalyze further fibril formation.
The modeling equations for the AC reaction pathway are
d½M
dt
¼ k1AC½M  k2AC½M½F1
d½F1
dt
¼ k1AC½M þ k2AC½M½F1
: (7)
These equations have an analytic solution:
½M¼½M0

k1AC þ k2AC½M0

exp
k1AC þ k2AC½M0t
k2AC½M0exp
k1AC þ k2AC½M0tþ k1AC

:
(8)
During our analysis, we chose to numerically integrate Eq. 7.
The AC model was used by Morris et al. (19) to fit a large
number of sets of protein aggregation kinetic data.
Monomer partitioning (MP) model
It has been suggested that the monomer species in some
systems may comprise multiple conformational states, of
which only a fraction can support fibril initiation (37). To
capture this schematic, the MP model posits that the mono-
mer population partitions into two conformational subspe-
cies, MA and MB, with parameter fMP as the fraction of
monomer in the ‘‘A’’ conformation. MA and MB are not
assumed to reequilibrate with each other as fibril growth
proceeds. This situation might arise, for example, upon rapid
change in denaturant concentration, trapping two alternate
conformations in local minimum energy wells. We assume
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constant k1MP but does not participate in fibril growth,
whereas the MB subpopulation does not initiate new fibrils
but adds to extant fibrils with a rate constant k2MP:
nMA/
k1MP
Fn
MB þ Fx/k2MP Fxþ1; xRn:
Similar to previous developments, ½F ¼ PN
i¼n
½Fi and k2MP is
assumed to be independent of x. The MP modeling equations
are
d½MA
dt
¼ nk1MP½MAn
d½MB
dt
¼ k2MP½MB½F
½MA0 ¼ fMP½M0
½MB0 ¼

1  fMP
½M0
d½F
dt
¼ k1MP½MAn:
(9)
These modeling equations have analytic solutions, for
example, if n ¼ 1, then
½MA¼ fMP½M0expðk1MPtÞ
½MB¼ ð1  fMPÞ
½M0exp

k2MPfMP½M0
k1MP

1  k1MPt  ek1MPt
	
:
(10)
We numerically integrated Eq. 9 during our analysis. To
compare the modeling equations to monomer-loss data, we
let ½MA þ ½MB ¼ ½M .
Sequential growth (SG) model
We considered the possibility that a soluble intermediate f
forms during aggregation. In the SG model, 1), n monomers
react irreversibly to form fn with a rate constant k1SG; 2), fn
converts to fibril Fn with a rate constant k2SG; and 3), M
adds to Fx with a rate constant k3SG:
nM/
k1SG
fn
fn/
k2SG
Fn
M þ Fx/
k3SG
Fxþ 1; xRn:
As before, k3SG is considered independent of x and
½F ¼ PN
i¼n
½Fi. The SG modeling equations are
d½M
dt
¼ nk1SG½Mnk3SG½M½F
d½f 
dt
¼ k1SG½Mnk2SG½fn
d½F
dt
¼ k2SG½fn:
(11)Soluble intermediates lack the defined structure, density,
and/or morphology of fully formed fibrils and thus may
not be detectable by assays such as sedimentation or thiofla-
vin T fluorescence. We therefore assumed, in fitting the SG
model to monomer-loss kinetic data, that the ‘‘monomer’’
response equals [M] þ n[fn].
Simple polynomial (SP) model
For completeness, we also considered empirical polynomial
models to describe monomer-loss kinetics. We limited
ourselves to only linear (SP1) and quadratic (SP2) expres-
sions:
½M ¼ ½M0ð1  k1tÞ (12)
½M ¼ ½M0

1  k1t  k2t2

: (13)
Equations 12 and 13 do not represent any implied mecha-
nism or reaction pathway.
It is clear that there are many variations on the above
models. In particular, we neglected schemes involving mech-
anisms of fibril growth or restructuring other than monomer
addition. We also did not consider any reaction pathways
with off-path agglomeration steps, and we limited ourselves
to models with no more than three parameters. One could
imagine combinations of mechanisms, for example, a combi-
nation of PN and SG models where a preequilibrated nucleus
is formed that then grows into a soluble aggregate before
maturing to fibrils. A modular approach for combining
different steps to generate a large number of combinatorial
models has been described recently (38). Still, we believe
this collection is sufficiently diverse for our purposes, and
is reasonably representative of the kinetic models that have
been published in the literature and used to interpret experi-
mental data.
Selection of test data sets and parameter
estimation
Development of representative monomer-loss kinetic
data sets
Our first objective was to establish test data sets to subject to
parameter estimation and model discrimination. To do this,
we adapted aggregation data published by others on three
different systems: the polyglutamine peptide K2Q36K (13),
the b-clam protein (16), and protein L (17). These data sets
were chosen because they all contained kinetic data taken
at several different concentrations and because all three
sets were analyzed in the original literature using Eq. 4 and
the log-log method described by Chen et al. (13). Our model
discrimination procedure requires full response data taken at
the same independent variable values (Eq. 1). Since aggrega-
tion rates generally decrease with concentration, we chose
to define our independent variable not as time (t) but as
t ¼ [M]0t. This reflects practice, as low-concentrationBiophysical Journal 96(7) 2871–2887
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high-concentration samples (e.g., (13,16,17)). In no case did
the published data fit the exact requirements of our model
discrimination procedure. Therefore, we were not able to
use the published data without modification; rather, the
published data served as a template for developing test data
sets. Each set will be discussed in turn.
PolyQ test data
Aggregation of polyglutamine peptide as a function of length
was studied by Wetzel and co-workers as a model system for
aggregation of huntingtin and related proteins that have been
linked to expanded CAG domain diseases (13). Monomer-
loss data for K2Q36K2 were collected based on a centrifuga-
tion assay in which peptide concentration in the supernatant
was measured by reverse-phase high-performance liquid
chromatography. Data at four initial concentrations were
reported (13). The published data did not report concentra-
tion measurements at the same t for all initial monomer
concentrations, nor were there the same number of data
points for each initial concentration (three points at the two
higher concentrations, and nine at the two lower concentra-
tions). Therefore, we used the published data as a template,
but we modified this template to produce a data set that
was amenable to model discrimination. For example, we
interpolated between the actual data points to obtain data
at the t values required. Our representative data set includes
four responses (at initial concentrations of 37, 17, 8.25, and
4.5 mM) and six t points (100, 200, 300, 400, 500, and
600 mM h) per response. These data are denoted as our
‘‘polyQ test’’ data set and are given in Table S1 in the
Supporting Material.
FIGURE 2 Graphical analysis of the monomer-loss kinetics of the polyQ
test data, as suggested by Chen et al. (13). The initial concentrations are
37 mM (-), 17 mM (), 8.25 mM (:), and 4.5 mM (;). (Inset) Slopes of
the best-fit lines versus the corresponding initial concentration. The slope
of this line is 2.59  0.07, and the intercept is 5.74  0.08.Biophysical Journal 96(7) 2871–2887The polyQ test data are plotted in Fig. 2 as [M] versus t
(per Eq. 4), following the analysis procedure described else-
where (13). The slopes for each initial concentration data set
were determined by linear regression. The inset to Fig. 2
shows a plot of log(slope) versus log[M]0. The slope of
the log-log plot for the polyQ test data is 2.59  0.07, similar
to the reported value of 2.68 for the original published data
(13). Since the slope ¼ nþ 2, this was interpreted in the orig-
inal literature as n ~ 1, indicating that the nucleus is a mono-
mer in equilibrium with the unfolded monomer pool. From
the intercept of Fig. 2 (inset), we obtained a value of
log(k1FA/2) ¼ 5.75  0.08 or k1FA ¼ 0.27 M2 s2, some-
what higher than the value of 0.09193 M2 s2 reported for
the published data (13).
Clam test data
CRABP I (cellular retinoic acid binding protein I) is
a member of the ‘‘b-clam’’ protein family whose folding
kinetics have been studied in detail. A slow-folding mutant
(P39A) is known to form inclusion bodies. Ignatova and
Gierasch measured in vitro aggregation of this mutant using
a probe that is fluorescent when bound to all nonnative states,
and using centrifugation followed by concentration determi-
nation of the supernatant (16). The published data were
modified slightly to meet the requirements of our model
discrimination method to generate the ‘‘clam test’’ data set
(Table S2). As with the polyQ test data, four concentrations
at six t points were included.
In the original literature, the data were analyzed using
Eq. 4 and the method described in Chen et al. (13). It was
concluded that n z 1, that aggregation proceeded via
a monomeric nucleus, and that ‘‘an unfavorable equilibrium
between the misfolded intermediate and the bulk pool of
monomers [was] causative in aggregation.’’ We analyzed
our clam-test data set using this method, to be sure that our
modified data were in keeping with the original, and simi-
larly found n ¼ 0.9  0.4. (Note that only a fraction of the
test data, at low-percent total aggregation, was used in this
analysis, because the analysis using Eq. 4 is valid only at
low aggregation. The full range of the test data set was
used in subsequent parameter estimation and model-discrim-
ination steps.)
Protein L test data
Protein L is a small a/b protein that aggregates in 25%
trifluoroethanol solutions. Aggregation kinetics were
measured using the thioflavin T assay (17), and the data
were analyzed using Eq. 4 and the ‘‘log-log’’ method (13).
From this analysis, it was concluded that the kinetic data
was consistent with linear elongation with a nucleus size
of 2 or 3. We adapted the published data slightly to meet
the requirements of our model-discrimination procedure
and generated the ‘‘protein L test’’ data set (Table S3). We
analyzed this test data set using the log-log method and
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Model n r2 k1 k2 k3 or fMP
PN 1 0.999 1.4 (1.1)  104 mM1 h1 5 (8)  103 mM1 h1
2 0.994 4 (7)  106 mM2 h1 5 (16)  103 mM1 h1
3 0.991 1.1 (2.5)  107 mM3 h1 5 (22)  103 mM1 h1
FA 1 0.998 1.1 (0.1)  106 mM2 h2
2 0.992 3.0 (0.6)  108 mM3 h2
3 0.989 8 (2)  1010 mM4 h2
SN 1 0.994 1 (5)  103 h1 2 (9)  102 mM1 h1
2 0.999 7 (6)  105 mM1 h1 1.1 (1.5)  102 mM1 h1
3 0.994 1.4 (2.4)  106 mM2 h1 1.5 (4.5)  102 mM1 h1
AC 0.994 2.5 (2.3)  103 h1 3.7 (2.8)  103 mM1 h1
MP 1 0.999 1.8 (0.9)  101 h1 5 (~)  100 mM1 h1 8.8 (1.9)  105 –
2 0.999 7 (~)  100 mM1 h1 2 (5)  100 mM1 h1 5 (8)  104 –
3 0.998 8 (~)  103 mM2 h1 6 (32)  101 mM1 h1 2 (8)  103 –
SG 1 0.999 1.4 (0.5)  101 h1 2.9 (1.0)  103 h1 1.3 (0.6)  101 mM1 h1
2 0.999 2.1 (1.4)  104 mM1 h1 1.9 (1.3)  101 h1 1.5 (5)  103 mM1 h1
3 0.999 5.6 (3.8)  105 mM2 h1 2.2 (0.6)  102 h1 2 (9)  103 mM1 h1
SP1 0.991 5.1 (1.3)  103 h1
SP2 0.995 7.6 (1.6)  103 h1 5 (2)  105 h2
Fitted value and the 95% confidence interval (in parentheses) are shown for each parameter. A tilde (~) in place of a numerical confidence interval indicates an
indeterminate parameter.found n ¼ 2.6  0.5, again demonstrating that our data set is
consistent with the published data.
Parameter estimation
The three test data sets were then used to obtain parameter
values by fitting each of the kinetic models to each data set
using the parameter estimation package Athena Visual
Studio. Where applicable, n was fixed to an integer value
of 1, 2, or 3; these models are denoted as, e.g., PN2 for the
preequilibrated nucleus model with n ¼ 2. In total, 18
different models were fitted to three different test data sets.
All modeling equations were modified to accommodate the
transformation of the independent variable from t to t.
A summary of the fitted parameters for the polyQ test data
is given in Table 1. We were able to determine numerical
values for all parameters, though in many cases the confi-
dence interval was very large. Confidence intervals were
generally smaller for those models with fewer parameters.
There are several specific results worth noting.
1. The fitted value of k1FA was 0.084  0.01 M2 s2,
roughly a factor of 3 smaller than the value obtained
from fitting Eq. 4 using the log-log method. This discrep-
ancy can be attributed primarily to the difference between
setting n ¼ 1 and fitting to n ¼ 0.59.
2. If the Ferrone approximation is adequate to analyze the polyQ
test data, then we should observe k1FA ¼ k1PNk2PN. A
comparison of the fitted values in Table 1 reveals that k1FA
is ~35–45% larger than k1PNk2PN, depending on the chosen
value ofn. This difference represents the error imposed by the
two simplifying assumptions used to derive Eq. 4.
3. With the SI model, the first reaction is indeed slower than
the second reaction. This is most directly observed at
n ¼ 2; at n ¼ 1 or n ¼ 3 the comparison requires consid-
eration of the monomer concentration.4. For the MP model, the fraction of monomer capable of
initiating fibril formation is strikingly small. However,
the uncertainty in the parameter values is large, due to
the high correlation between fMP and the rate constants.
5. In the SG model, formation of the soluble intermediate f is
faster than conversion of f to F; thus, f accumulates during
early times.
The r2 values for each fit are listed in Table 1; no r2 value
was <0.989, which is usually taken to indicate a good fit for
each model. Visual confirmation of the adequacy of the fit
was obtained by plotting the fitted curves against the test
FIGURE 3 Representative model solutions for the polyQ test data set. The
37 mM test data (-) and the corresponding PN1 (solid line), FA1 (dashed
line), SI2 (dash-dotted line), and SG3 (dotted line) model solutions are
plotted against the transformed time variable as t ¼ [M0]t. The SI2 and
PN1 model solutions for 37 mM are virtually indistinguishable at this
resolution.Biophysical Journal 96(7) 2871–2887
2878 Bernacki and Murphydata; a selection of model solutions is plotted against the
37 mM Poly Q test data in Fig. 3.
Similarly, the clam test and protein L test data sets were fit
to the 18 various kinetic models. In all cases, parameter esti-
mates were obtained by nonlinear regression, and good fits,
as characterized by r2, were observed (not shown).
Model discrimination of three test data sets
We next applied our model discrimination procedure to eval-
uate the competing kinetic models. The modeling equations
were numerically integrated using the fitted parameter values
(shown for polyQ (Table 1), but not for clam and protein L
test sets) to obtain the model solutions versus t. Equations
1 and 2 were used to calculate the normalized posterior prob-
ability of each model on the basis of the test data set. We will
discuss each test data set in turn.
Results of our evaluation of the validity of various models
to describe the polyQ test data are plotted in Fig. 4 a. None of
the kinetic models is a clear winner. The SG3 model has the
greatest posterior probability share, though the PN1, FA1,
SI2, MP2, and SG1 models also have sizable shares. Further-
more, many of the other models do not lag far behind; most
notably, the PN and FA models with n ¼ 2 or 3 possess
~65% of the posterior probability share of the PN1 and
FIGURE 4 Model discrimination results for the (a) polyQ test, (b) clam
test, and (c) protein L test data sets. (a) For the polyQ test data, the SG3
model has the highest share (0.096), followed by the SI2 (0.081), PN1
(0.081), FA1 (0.078), SG1 (0.076), and MP2 (0.070) models. (b) For the
clam test data, the MP2 has the highest share (0.15), followed by the MP3
(0.10), SI1 (0.073), and SG3 (0.072) models. (c) For the protein L data,
the FA2 has the highest share (0.14), followed by the FA3 (0.11), SI3
(0.097), and PN2 (0.097) models.Biophysical Journal 96(7) 2871–2887FA1 models. We conclude that the correct mechanism
cannot be reliably ascertained from the data (Fig. 2 and
Table S1), as there is no single model with a dominating
posterior probability share. Specifically, this analysis shows
that these data are insufficient to draw the conclusion that
polyglutamine aggregation proceeds via a preequilibrated-
nucleation mechanism with a monomeric nucleus.
We completed a similar analysis of the clam test data to
calculate the posterior probability of each model. For this
case, the MP2 model was deemed the most probable
(Fig. 4 b). PN1, the model chosen in the literature, was
less than half as likely as MP2 to be the appropriate model.
Furthermore, several other models had posterior probabilities
similar to PN1, indicating that they are equally adept at
describing the experimental data. Thus, one cannot conclude
based on this monomer-loss data that b-clam protein aggrega-
tion proceeds through a misfolded intermediate that serves as
a monomeric nucleus. Our analysis suggests that the most
probable mechanism involves the presence of two alternate
protein conformations at initiation of aggregation, only one
of which is capable of initiating aggregation. However,
conclusive evidence for this is lacking, as several other
kinetic models had nonnegligible probabilities.
For the protein L test data, there was again no clearly supe-
rior kinetic model. The FA2 model yielded the highest prob-
ability (Fig. 4 c). It is interesting that the PN2 model, from
which the FA2 is obtained via simplifying assumptions,
achieves less probability share than FA2. This could be
due to the narrow timescale and concentration range over
which the original data were collected; there is no added
benefit of the PN2 model over FA2 at fitting long-time
data, and PN2 is penalized because of its additional param-
eter. A variety of other models (PN3, FA3, SI3, MP3, and
SG3) have similar posterior probabilities. Our analysis
supports a conclusion that the reaction is second- or third-
order, but no definitive distinction among the various mech-
anisms can be made, and one cannot conclude definitively
that aggregation proceeds via a dimeric or trimeric preequi-
librated nucleus.
In summary, with three different sets of monomer-loss
kinetic data derived from the literature, we were able to
obtain good fits of the data to several kinetic models. We
developed a method to discriminate among different models
and determine which was the most probable. We demon-
strated that although some models could be ruled out in
each case, the data sets were insufficient to positively deter-
mine a unique mechanism of aggregation.
Effect of experimental error and data quantity
We next asked, given ‘‘data’’ generated from a model solu-
tion, 1), will our parameter estimation method recover the
correct parameter values? and 2), will our model discrimina-
tion procedure successfully identify the correct model and
eliminate incorrect models?
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the fitted parameters from the polyQ-test data set: k1PN ¼
1.4  104 mM1 h1 and k2PN¼ 5.4  103 mM1 h1.
We chose four initial concentrations ([M]0 ¼ 40, 30, 20,
or 10 mM) and six transformed time points (t ¼ 100, 200,
300, 400, 500, and 600 mM h). Equation 3 was numerically
integrated with n ¼ 1 to calculate [M] versus t. A normally
distributed random number with s ¼ 1 mM was added to the
calculated values to simulate experimental error. This
process was repeated three times to generate three sets of
simulated monomer-loss data; these data sets will be referred
to as simulation 1, simulation 2, and simulation 3. These
simulated data sets are available in Table S1.
The three simulation data sets were first analyzed using
Eq. 4 and the graphical method described earlier (13).
The n values determined in this manner were 1.7  0.2,
0.4  0.3, and 0.8  0.3. This simple examination shows
that analysis of monomer-loss data using Eq. 4 could
lead to erroneous conclusions about the nucleus size, even
presuming that the PN mechanism is correct, because of
the influence of experimental error. The values of k1FA
obtained in this manner for each data set were, respectively,
0.0082, 0.59, and 0.13 M2 s2; given that k1FA ¼ k1PNk2PN,
the anticipated value was 0.058 M2 s2. Again, we observe
that experimental error can lead to large variability in param-
eter estimates when this methodology is used.
We next evaluated the simulated data using our parameter-
estimation and model-discrimination procedures, to deter-
mine if we could 1), recover the input model parameter values;
and 2), uniquely ascribe the data source as the PN1 model
solution. Fitted PN1 parameter values are provided in Table
2. The regressed parameter values differed from each other
by one or more orders of magnitude. This result was
surprising, given that all three data sets were acquired by
simply incorporating error (2.5–10% relative error, depend-
ing on the initial concentration) into the exact model solu-
tions. Note, however, that the product of the two parameters
(k1PN1k1PN1 ¼ 0.11, 0.11, and 0.062 M2 s2) does not
TABLE 2 Fitted parameters for the PN1 model regressed to
simulated data sets
Data set k1PN (10
4 mM1 h1) k2PN (10
4 mM1 h1)
Input parameters 1.4 54
Simulation 1 0.11 (~) 1300 (200)
Simulation 2 0.0025 (~) 58,000 (8000)
Simulation 3 0.8 (1.7) 100 (300)
Triplicate 1.6 (1.1) 40 (60)
Extensive 1.1 (0.5) 77 (48)
Fibril 1.4 (0.2) 52 (16)
Time 1.0 (0.9) 73 (71)
Fibril þ time 1.4 (0.1) 54 (5)
Data sets were obtained by solving the PN1 model equations at the input
parameter values and then adding a random error to the calculated values.
The data were then regressed to the model equations. Ideally, the input
parameters would be returned. The values presented are the fitted parameters
(95% confidence interval).vary nearly as much as the individual values, nor is there as
much variability as when the data were fit to Eq. 4 using the
graphical method. This indicates that the lumped parameter
can be ascertained with better certainty than the individual
parameters, and that the two parameter values are highly
correlated with each other.
Finally, the simulation data sets were fit to all 18 kinetic
models to find model parameters. The normalized posterior
probabilities obtained from evaluating model fits to the simu-
lated data are shown in Fig. 5. It was surprising that the PN1
model, from which the data were actually derived, was never
the highest-ranking model. Rather, the FA model was
selected for all three data sets as most probable. The FA1
model had the highest posterior probability for simulation
1, and the FA2 was the highest for simulation 2, even though
the graphical method indicated the reverse: a dimeric nucleus
for simulation 1 and a monomeric nucleus for simulation 2.
In no case was the FA model strongly preferred over all other
models, and the next-best models varied significantly among
the different simulation data sets. We suspect that the FA
models do relatively well for two reasons: first, they incur
the smallest parameterization penalty (Eq. 1), and second,
there is insufficient data at long times to provide an advan-
tage to the PN model that compensates for the additional
parameter.
We wondered whether an increase in the quantity of data
would improve parameter estimation and/or model discrimi-
nation. Specifically, we evaluated the importance of replicate
FIGURE 5 Model discrimination results for the data sets from (a) simula-
tion 1 (b) simulation 2, and (c) simulation 3. The models with the highest
posterior probabilities are the FA1 (0.11) for simulation 1, FA2 (0.13) for
simulation 2, and FA1 (0.14) for simulation 3.Biophysical Journal 96(7) 2871–2887
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points. We generated two new simulated data sets from the
PN1 model. The ‘‘triplicate’’ simulated data set had three
‘‘measurements’’ for each initial concentration (40, 30, 20,
and 10 mM) at each t value (100, 200, 300, 400, 500, and
600 mM h), whereas the ‘‘extensive’’ simulated data set had
100 single ‘‘measurements’’ taken much more frequently
over the same t range (6, 12, 18 . 588, 594, 600 mM h).
The triplicate and extensive data sets are given in Table S1
and Table S4, respectively.
Graphical analysis of the triplicate data set produced an
estimate of n ¼ 1.0  0.1, consistent with the PN1 model
used to simulate these data. Furthermore, fitted parameter
values for the PN1 model were close to the input values,
although the confidence intervals were still large (Table 2).
Thus, replicate measurements greatly improve the reliability
of parameter estimates. However, the model discrimination
results did not improve (Fig. 6 a); indeed, the SG1 model
had the highest posterior probability share by a considerable
margin. With the large number of replicates in the triplicate
data set, ve is large, and a slight decrease in the residual error
confers a significant advantage (Eq. 1); as such, the influence
of the parameterization penalty lessens as the number of repli-
cates grows. This may explain why a three-parameter model
such as the SG1 is selected over the two-parameter PN1
model. Thus, including replicate measurements greatly
improves the accuracy of parameter estimates once a mecha-
nism is assumed. Replicates become increasingly important
as the number of parameters and the model complexity
increase. However, replicates alone are not sufficient to
successfully discriminate among alternative mechanisms.
In the extensive data set, we increased the number of data
points (without replicates) within the same transformed time
domain. Graphical analysis of this data set based on Eq. 4
FIGURE 6 Model discrimination results for the (a) triplicate and (b)
extensive data sets. The SG1 model has the largest share for the triplicate
data set (0.57), whereas the FA1 model has the largest share for the extensive
data set (0.098).Biophysical Journal 96(7) 2871–2887yielded a value of n ¼ 0.76  0.01. Regression to the PN1
model led to parameter estimates that are close to the input
values, with tighter confidence intervals than those obtained
with the triplicate data set (Table 2). FA1, PN1, and SI2 were
selected as the most probable models (Fig. 6 b), with several
other models having smaller, but still significant, probability
shares. Thus, a unique mechanism cannot be identified from
these data with any confidence. We conclude that increasing
the quantity of experimental data improves parameter esti-
mation but not model identification.
Data requirements for successful model
discrimination
Our analysis showed that replicates or an increased number
of data points improve parameter estimation but not model
discrimination. We next explored whether changing the
nature of the experimental data would improve model
discrimination. We examined two cases: 1), fibril-growth
kinetics in addition to monomer-loss kinetics; and 2), mono-
mer-loss data collected over much longer timescales.
Addition of ﬁbril-growth data
The PN, FA, SI, MP, and SG models all include equations
for fibril growth. Note that [F] in Eqs. 3, 5, 6, 9, and 11 is
the molar concentration of fibrils, not the mass concentra-
tion. It is possible to calculate the molar fibril concentration
from simultaneous measurement of the mass of fibrils and
the average fibril molecular weight, obtained directly or indi-
rectly through static light scattering, atomic force micros-
copy, or other experimental techniques. Because these
measurements are more difficult to carry out, there is much
less published data on fibril size and growth kinetics than
on monomer-loss kinetics. With the AC model, fibril size
is irrelevant as the fibrils are presumed to grow by an unspec-
ified coalescence mechanism. The SP model is an empirical
fit of monomer-loss data and therefore does not provide
a means for calculating [F] versus time. Therefore, we did
not include the AC or SP models in this analysis.
We again used the PN1 model with k1PN ¼ 1.4  104
mM1 h1 and k2PN¼ 5.4  103 mM1 h1 to generate
the simulated data. We obtained model solutions at four
different initial concentrations (40, 30, 20, and 10 mM)
through numerical integration of Eq. 3 and calculated [F]
as well as [M] versus t. Random normally-distributed errors
(sM ¼ 1 mM , sF ¼ 0.07 mM) were added to simulate exper-
imental error; the variance for the simulated fibril data was
chosen to give the fibril data a similar percent error as the
monomer data. This ‘‘fibril’’ data set spans the same t range
(0–600 mM h), but contains 10 rather than six data points at
each concentration, to maintain the matrix dimensions neces-
sary for model discrimination (Eq. 1). The fibril data set is
provided in Table S5.
We first fit the PN1 model equations to the fibril data set to
obtain estimates of the model parameters. Inclusion of fibril
Models of Aggregation Kinetics 2881kinetic data greatly improved the accuracy and precision of
the parameter estimates (Table 2). We next fit the fibril
data set to the PN, FA, SI, MP, and SG models at n ¼ 1,
2, and 3, and calculated the normalized posterior probability.
It was surprising that the SI2 model had a much greater
posterior probability share than the PN1 model from which
the data were actually obtained (Fig. 7 a). This is akin to
a false positive; analysis of this data set would lead to the
conclusion that the slow-initiation model with n ¼ 2 was
superior to the model actually used to generate the simulated
data.
Increased percent monomer loss
We next tested whether including data over a longer time
period, and thus a greater percent monomer loss, would
improve parameter estimation and model discrimination.
We simulated monomer-loss data directly versus t, rather
than versus the scaled time variable, t. The time range was
chosen so that ~90% of the monomer at [M]0 ¼ 40 mM
aggregated over the course of the ‘‘experiment’’; the six
time points used were 15, 30, 45, 60, 75, and 90 h. The
time data set is included in Table S5. The parameter regres-
sion was improved in comparison to the simulation data sets
(Table 2). Collecting data over a longer time period also
somewhat improved model discrimination, in that more
models were determined to be unsatisfactory (Fig. 7 b).
The FA models were clearly unable to describe this data
set, which is to be expected, as the approximations leading
FIGURE 7 Model discrimination results for the (a) fibril, (b) time, and (c)
fibril þ time data sets. The SI2 has the largest share (0.56) for the fibril data
set, three models tie for the largest share (0.18) for the time dataset, and the
PN1 has the largest share (0.83) for the fibril þ time dataset.to the FA equations are reliable only when there is little
(~10–20%) monomer loss. Still, there were several models
with similar probabilities; these included the correct model
(PN1) as well as various incorrect models (SI2, MP2, SG2,
and SG3).
Addition of ﬁbril data plus increased percent monomer loss
Finally, we combined both ideas: the ‘‘fibril þ time’’ data
set (Table S5) included fibril data and was measured versus
t to ~90% monomer loss. At each initial monomer concen-
tration, data was generated at 10 equally spaced time points
up to 90 h. Both parameter estimation and model discrimi-
nation were highly successful with the fibril þ time data set.
Parameter estimates obtained by fitting to the PN1 model
equations were identical to the input values, and the confi-
dence intervals were small (Table 2). Furthermore, the PN1
model was selected as the correct model via our model-
discrimination analysis: the posterior probability of the
PN1 model was more than an order of magnitude higher
than the next best model (Fig. 7 c). A comparison of the
data and model solutions at [M]0 ¼ 40 mM is given in
Fig. 8. Though many of the competing models successfully
track the monomer-loss data (Fig. 8 a), only the source PN1
model also captures the fibril data without systematic devi-
ation (Fig. 8 b). Most notably, the model discrimination
analysis of the fibril þ time data successfully indicated
the correct model despite excellent fits from the competing
models. Ten of the 12 models had r2 values >0.95, with the
SG2 model nearly matching the r2 of the source PN1 model
(0.989 vs. 0.990). Thus, a high r2 value alone is not suffi-
cient to conclusively identify a particular kinetic scheme
as correct.
To ensure that our conclusions are general, and not
specific to PN-type aggregation mechanisms, we expanded
FIGURE 8 Representative model solutions for the fibril þ time data set.
The 40 mM monomer-loss (a) and fibril-growth (b) data (-) and the corre-
sponding PN1 (solid line), FA1 (dashed line), SI2 (dash-dotted line), and
SG3 (dotted line) model solutions are plotted versus time.Biophysical Journal 96(7) 2871–2887
2882 Bernacki and MurphyFIGURE 9 Model discrimination results for the (a) MP2
simulation, (b) MP2 fibril þ time, (c) SG2 simulation, and
(d) SG2 fibril þ time data sets.our analysis to include two other mechanisms, MP2 and
SG2. Model equations were solved, using parameters ob-
tained by fitting the clam (MP2) or protein L (SG2) test
data sets. These solutions were then used to generate either
monomer-loss data (‘‘MP2 simulation’’ or ‘‘SG2 simula-
tion’’), or monomer-loss plus fibril-growth data to ~90%
total aggregation (‘‘MP2 fibril þ time’’ or ‘‘SG2 fibril þ
time’’). Experimental error was added to each solution
generated by the models, and then the resulting simulated
data sets were fitted to the various kinetic models. The data
sets used in this analysis are given in Table S2, Table S3,
Table S6, and Table S7.
Results of this analysis are summarized in Fig. 9. With the
MP2 simulation data, our model discrimination process was
able to identify the MP2 model as the most probable
(Fig. 9 a), but two other models, the SI2 and the PN1, also
had substantial posterior probabilities. Addition of the fibril-
growth data increased the MP2 probability and provided for
more robust identification of the correct mechanism (Fig. 9 b).
Model discrimination was poor with the SG2 simulation data
(Fig. 9 c) as was found with the PN1 simulation (Fig. 5).
Marked improvement was obtained if fibril-growth data was
analyzed along with monomer-loss data, and the data were
collected over most of the aggregation process (Fig. 9 d). In
this case, SG2 was clearly identified as the correct model.
Thus, we conclude that both monomer-loss and fibril-
growth data, extending over nearly the entire aggregation
process, are necessary to discriminate between competing
aggregation models. It is important to point out that the
complementary statement can also be made: given mono-
mer-loss and fibril-growth data extending over the aggrega-
tion process, discrimination among different aggregation
mechanisms is robust, and the correct model can be identified.Biophysical Journal 96(7) 2871–2887Characteristics of nucleated growth:
concentration-dependent lag times and seeding
A lag time that decreases with concentration and the elimina-
tion of this lag phase by the addition of preexisting fibrils
(‘‘seeding’’) are frequently considered to be diagnostic of
nucleated growth (4,6,8,16,28,39,40). We examined which
of our models were able to capture these behaviors.
To do this, we used the parameter estimates in Table 1,
then obtained model solutions at [M]0 ¼ 0.1 mM, 0.5 mM,
and 1.0 mM. Depending on the concentration and parameter
values, all models were able to produce sigmoidal monomer-
loss profiles, with apparent lag phases (not shown). We note,
FIGURE 10 Effect of seeding. The initial concentrations simulated were
[M]0 ¼ 0.5 mM and [F]0 ¼ 0 mM (solid lines) and [M]0 ¼ 0.5 mM and
[F]0 ¼ 0.005 mM (dotted lines). Solutions for the PN1 (a) and MP2 (b)
models were obtained using the parameter values listed in Table 1.
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we define a true lag phase as a time period during which there
is no aggregation. A true lag phase requires a stochastic
aggregation model. Rather, the apparent lag phase we
observed is indicative of a slow aggregation rate during early
times and a faster aggregation rate at intermediate times.
With the exception of the AC and SG1 models, the lag
time decreased strongly with concentration. For example,
with the MP2 model, the time to 1% aggregation increased
from 86 h at [M]0 ¼ 1.0 mM to 864 h when [M]0 ¼ 0.1 mM.
We conclude that sigmoidal monomer-loss kinetics and
a concentration-dependent lag time are not diagnostic of
any unique aggregation model.
We simulated seeding by using a nonzero [F] at t ¼ 0.
Specifically, we calculated the monomer-loss profiles with
[M]0 ¼ 0.5 mM and [F]0 ¼ 0.005 mM, using the parameter
values given in Table 1. We were surprised to find that there
was virtually no change in monomer-loss kinetics with the
PN1 model (Fig. 10 a), whereas a drastic seeding effect
was observed with the MP2 model (Fig. 10 b). There was
no effect of seeding in the AC or SG1 models, small effects
with PN2, SI1, SI2, SG2, and SG3, and moderate
effects with PN3 and SI3; the largest effect of seeding was
observed with the MP series of models (not shown). Thus,
we conclude that the absence of a significant seeding effect
does not necessarily rule out nucleated growth, nor does
the presence of a seeding effect provide definitive proof of
any specific aggregation mechanism. Furthermore, seeding
experiments cannot be used in model discrimination unless
the molar fibril concentration is known; in most published
experiments, only the fibril mass concentration is reported.
DISCUSSION
Protein aggregation, and particularly fibril growth, has
received considerable attention over the past few years
because of its negative effects in degenerative amyloid
diseases and in the manufacture of protein pharmaceuticals.
On a more positive front, controlled self-assembly of
peptides and proteins into supramolecular structures affords
the opportunity to design novel materials with unique func-
tional properties. Knowledge of the pathway by which
aggregates form, and their rate of formation, is critical infor-
mation as researchers aim to develop methods and reagents
for reliable control of aggregation.
There is a growing body of literature in which the kinetics
of protein aggregation is measured quantitatively and the
data are interpreted mechanistically. A simple, but widely
used, approach for quantitative analysis of kinetic data is
illustrated in other studies (13,15–17). By limiting data anal-
ysis to the first ~10–20% of the aggregation process and by
assuming that the rate of fibril elongation exceeds that of
fibril nucleation, a simple algebraic expression (Eq. 4) is
derived. Monomer concentration is predicted to decrease
with a t2 dependence, and monomer-loss kinetics are charac-terized by a single lumped rate constant, k1FA, and the size of
the aggregation nucleus, n. This algebraic equation, first
described by Ferrone (11), is derived from a more complete
nucleation-based aggregation model; this model assumes
that monomers are in rapid and reversible equilibrium with
an energetically unfavorable nucleus, and that this nucleus
(and subsequent fibrils) grows by monomer addition. It is
important to note that the conclusions derived from this
type of analysis have been used to motivate and inform theo-
retical studies on the structure of the nucleus (e.g., (41)) and
the connection between aggregation and toxicity (e.g., (28)).
However, there has not been a systematic evaluation of the
validity of applying Eq. 4 to kinetic data or the robustness
of any mechanistic interpretation based on the outcome of
this analysis.
Some researchers have applied more detailed and sophis-
ticated kinetic models to analyze their data. For example,
Collins et al. derived differential equations for aggregation
of the yeast prion protein Sup35 that included nucleation,
growth, and fibril fragmentation steps, but they fit only
a linearized version of the model to their data (22). Ruschak
and Mirankar (23) derived a set of differential equations
involving three rate constants for primary nucleation,
secondary nucleation, and elongation. All steps were
assumed irreversible and the rate constants were fit to kinetic
data for IAPP aggregation. Assembly of the FtsZ protein, as
measured by a fluorescence assay, was fit to a six-parameter
model that included forward and reverse steps for monomer
activation, dimerization, and elongation (21). The researchers
reported that they achieved an excellent fit to the model. In
a very recent report, Xue et al. (38) developed a clever
modular approach for generating a library of aggregation
models. Kinetic data on b2-microglobulin aggregation were
collected to obtain lag times and lumped rate constants.
Several models were fitted to these parameters by least-
squares regression, and the models were ranked based on
goodness-of-fit criteria, with a penalty assessed based on
the number of parameters. The spirit of this work is similar
to ours, although the approaches and goals are distinct.
The goals of this work were 1), to examine the validity of
Eq. 4 in fitting experimental kinetic data; 2), to compare the
accuracy of parameter estimates obtained from linearized,
graphical approaches versus nonlinear regression methods;
3), to develop a method for discriminating among different
kinetic formulations; and 4), to define the nature of the exper-
imental data needed for robust parameter estimation and
model discrimination.
Experimental issues
Experimental methods for measuring fibril formation kinetics
include thioflavin T fluorescence, turbidity, sedimentation,
size exclusion chromatography, circular dichroism, and filtra-
tion assays. In general, these techniques report (or are
assumed to report) the mass of protein/peptide in the fibrillar
state or the mass of nonaggregated monomer, which are oftenBiophysical Journal 96(7) 2871–2887
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ing the data obtained using these methods. For example, small
soluble oligomers will not be differentiated from monomers in
filtration or sedimentation assays, and such oligomers will not
be detected by circular dichroism if they lack regular
secondary structure. Thioflavin T fluorescence is insensitive
to nonamyloid aggregation, and because the dye binds to
the surface of large aggregates and its fluorescence intensity
is partially dependent on morphology, the technique might
not accurately assay the mass of fibrils. To maintain our focus
on data fitting and model discrimination, we did not consider
these experimental uncertainties in our analysis. Following
along with the general practice, we assumed that measure-
ments of monomer concentration were reliable and, except
where otherwise noted, that only monomers and fibrils were
present.
Parameter estimation
Equation 4 is derived from the PN mechanism, but data anal-
ysis using Eq. 4 requires the application of two simplifying
assumptions. The graphical method recommended by Chen
et al. (13) requires further transformations of the data that
can skew the experimental errors so that they are no longer
randomly distributed. We evaluated the ‘‘polyQ test’’ data
set and found, when the data were analyzed, that there was
as much as a fourfold difference in the lumped rate constant
k1FA obtained using 1), the graphical log-log method; 2),
nonlinear regression fit directly to Eq. 4; or 3), nonlinear
regression via numerical integration of the PN model equa-
tions (Eq. 3). We also found that the log-log method was
sensitive to experimental error; for example, within our three
simulation data sets, estimates of n varied from 0.5 to 1.7,
and the lumped rate constant varied from 0.0082 to 0.59
M2 s2. Thus, extreme care must be taken not to place
too much confidence in the numerical values of n or k1FA ob-
tained by these methods.
We next evaluated the ability of a nonlinear regression
multiresponse analysis method to fit kinetic data to a variety
of model equations. Our three test data sets were developed
from published data from three different sources (13,16,17)
and are representative of the type of data that is generally
available for kinetic analysis. It was interesting that we
were able to obtain fitted parameter values for almost all of
the models that we attempted. Confidence intervals varied
significantly; as a general rule, fewer fitted parameters meant
tighter confidence intervals. For example, in fitting the polyQ
test data set to the PN1 model, we obtained parameter esti-
mates with large confidence intervals, whereas the same
data set fit to the FA1 model generated a lumped parameter
with a small confidence interval (Table 1). This result is
initially surprising, as FA1 represents an approximate solu-
tion to the full PN1 model, but it is most likely because of
high correlation between the two PN1 parameters; in other
words, the product of the PN1 parameters is known more
accurately than the individual parameter values. This anal-Biophysical Journal 96(7) 2871–2887ysis suggests that parameter error estimates from overly
simplified models may be misleadingly small. On the other
hand, although more complex models (which include for
instance fibril fragmentation or secondary nucleation) may
more accurately describe the true physical situation, the
increased number of unknown variables increases the uncer-
tainty of fitted parameter values.
The quantity and nature of the experimental data also
greatly affects the quality of the resultant parameter esti-
mates. We show (Table 2) that replicate experiments, more
frequent data collection, and expansion of the time over
which monomer-loss data are taken all improve the reli-
ability of the parameter estimates. These factors must be
carefully considered in the experimental design.
However, a good fit of a model to data does not mean that
the underlying mechanism must be correct! When we simu-
lated data using one model, and then fit alternate models to
the simulated data, we were able to obtain parameter esti-
mates for nearly all of the models (data not shown). As
such, we disagree with the statement that obtaining a good
fit indicates that the ‘‘mechanism must be portraying at least
some of the key features of the more complete, elementary
step process of protein agglomeration’’ (19). We frequently
obtained ‘‘good’’ parameter estimates (i.e., small confidence
intervals) and ‘‘good’’ fits (i.e., high r2) with models that did
not earn a high posterior probability. Thus, one must not
interpret a good fit as equivalent to identification of the
correct mechanism.
Model discrimination
Parameter estimation is only the first step in identifying the
aggregation mechanism from data. The next step is determi-
nation of the uniqueness of the proposed mechanism at
fitting the experimental data. The model discrimination
method we demonstrate here evaluates the probability that
a specific model is the best model, given a library of alterna-
tives. Of importance, we penalize models that require
additional parameters; a better fit should nearly always be
obtained by adding parameters, but the addition of parame-
ters must be justified by providing a statistically superior
fit of the data. In other words, the added complexity of the
model must be required by the data.
Our results clearly show that it is essentially impossible to
select a unique mechanism among candidate models based
solely on monomer-loss kinetic data. In particular, we argue
that simplified approaches such as Eq. 4, in which monomer-
loss data over the first 10–20% of the aggregation process is
utilized, should be considered empirical curve-fitting exer-
cises, from which no underlying mechanistic interpretation
of the fitted parameters can be reliably obtained. By trun-
cating the data at early times, as required by the assumptions
underlying Eq. 4, one ignores the longer-time data that
significantly contributes to differential identification of
models (compare Fig. 5 with Fig. 7 b). Our analysis calls
into question, for example, the conclusion that polyglutamine
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via a thermodynamic nucleus of size n¼ 1 (13–16). Our claim
is not that this conclusion is necessarily false. Rather, we
claim that no definite conclusion about mechanism is justified
based on the published analyses.
An examination of the model equations explains in part
why it is difficult to interpret a mechanism, especially based
only on monomer-loss data taken at early times. The func-
tional form of the d[M]/dt equations are very similar for
many of the different models (for example, compare Eqs.
3, 6, and 7). Greater differences are observed when fibril
growth is accounted for. Fibril growth affects kinetic
behavior both directly, through the d[F]/dt equations, and
indirectly, through the contribution of [F] to the d[M]/dt
equations, a contribution that becomes increasingly influen-
tial as aggregation progresses. It is important to note that the
equations are coupled. For example, the d[M]/dt equations
for the PN1 and the SI2 models are identical, but the d[F]/dt
equations differ, and since [F] appears in the d[M]/dt equa-
tions, the net result is differences in the monomer-loss kinetic
patterns. This explains the basis for our result showing that
both monomer-loss and fibril-growth data over the entire
aggregation process are necessary to discriminate among
competing models. It is not possible, using data sets that
encompass only the early stages of monomer loss or that
lack fibril kinetic data, to adequately distinguish between
even simple aggregation models. Indeed, in some of the cases
we simulated, insufficient data led to an incorrect conclusion
about the underlying mechanism (e.g., Figs. 6 a, 7 a, and 9 c).
Robust identification of the underlying kinetic mechanisms
requires experimental data on monomer loss that cover the
full timespan of the aggregation process, plus measurements
of the fibril size (or, equivalently, the fibril molar concentra-
tion) over time. Additional experiments to detect the presence
of intermediates may be needed to rule out oligomer-based
mechanisms, such as the SG model.
Kinetic models and physical interpretation
For the purposes of our study, we derived simple kinetic
models that often produced similar, though not identical,
modeling equations. Although the model equations may
appear mathematically similar, the underlying physics of
these models are distinct. The PN model assumes rapid
equilibration between monomers and a nucleus with
a defined structure. In other words, in the PN model, the
nucleus exists as an identifiable species, and the rate of inter-
conversion between the monomer and nucleus is sufficiently
fast that the concentration of the nucleus and the monomer
are related to each other at all times by the equilibrium
constant. A sigmoidal aggregation curve is attributed to
a very low equilibrium concentration of nuclei (Fig. 1). In
the SI mechanism, irreversible conversion of monomers to
an aggregate is assumed, and sigmoidal monomer loss is
obtained if the creation of aggregates is slow relative to their
growth by monomer addition. In the SI model, the monomermay be conformationally heterogeneous, and there are no
defined metastable structured nuclei before the appearance
of the smallest fibrils (Fig. 1). A key point of contrast
between the PN and the SI models is in the nature of the
collision that leads to fibril formation. In the PN1 model,
there is a two-step process: first, rapid reversible conversion
between the bulk monomer and an alternate conformation
(the nucleus), and second, collision between a monomer in
the bulk and this rare alternate conformation that produces
the first fibril. In the SI2 model, in contrast, a collision
between any two monomers in the bulk produces the first
fibril. Some of these distinctions between PN- and SI-type
schematics are discussed in greater detail in the literature
(e.g., (42,43)). In the MP model, one assumes that monomers
are initially trapped in two distinct conformations that do not
interconvert; as an example, during refolding, a protein may
be divided into natively folded and misfolded species, with
a large energy barrier separating the two forms. One confor-
mation is then assumed to be capable of initiating aggrega-
tion, whereas the other conformation can only add to existing
aggregates. The SG model is distinct from the other mecha-
nisms in that oligomeric intermediates are allowed to accu-
mulate until they convert to fibrils. This mechanism posits
the appearance of unstructured oligomers that eventually
undergo a conformational transition to structured fibrils.
Both the MP and SG models require three parameters and
both can exhibit sigmoidal aggregation kinetics in multiple
mechanistic regimes, especially because the ‘‘monomer’’
response is treated as MA þ MB and M þ nfn in the MP
and SG models, respectively.
‘‘Seeding’’ is often considered indicative of nucleated
growth. We observed, with interest, that the MP model was
the most sensitive to seeding of all the mechanisms tested.
This result was unexpected, as responsiveness to seeding
has sometimes been used as evidence for PN-type mecha-
nisms. We found that the PN and SI models are strongly
sensitive to seeding only when the size of the nucleus (n) is
large. The response is also strongly dependent on the molar
concentration of seeds, a concentration that can be calculated
only if one has data on the size of the aggregates used as
seeds. Our analysis demonstrates that the mechanism cannot
be identified simply by examination of the shape of the mono-
mer-loss kinetic profile or the response to seeding.
In our development of model equations, we focused
primarily on monomer-loss mechanisms, because there are
more examples in the literature of quantitative analysis of
monomer-loss data than of fibril-growth data. Yet, our anal-
ysis points out the critical need for experimental data on the
size of fibrils and the rate of fibril growth to differentiate
among various mechanisms. Monomer addition was the
only allowed mechanism for fibril growth in the models
we considered. We neglected many of the complexities of
fibril growth, such as fibril fragmentation, fibril-fibril coales-
cence, and formation of off-path agglomerates. Such steps
can be readily incorporated into reaction pathways; however,Biophysical Journal 96(7) 2871–2887
2886 Bernacki and Murphythese steps will involve additional parameters. Thus, accu-
rate parameter estimation and model discrimination for these
more complex models will place even greater demands on
high-quality fibril data. In particular, these added complex-
ities may necessitate data on the size distribution of fibrils
and a more rigorous modeling treatment of distinct Fx
species. Nevertheless, the approach developed here can be
easily modified to determine whether the data require, for
example, that fibril fragmentation or off-path aggregation
be considered.
In conclusion, we note that in deriving kinetic model equa-
tions from mechanisms, we implicitly assumed that the reac-
tion order is directly related to the reaction stoichiometry.
This assumption is almost universally made in the aggrega-
tion kinetics field, but it deserves closer examination. This
assumption is strictly valid only if the reaction is elementary,
that is, if the reaction involves a single reaction step and
a single transition state, without any reaction intermediates.
Given that a step such as monomer addition to a fibril
involves no covalent bond making or breaking, but likely
does involve the making and/or breaking of multiple
hydrogen bonds, as well as changes in excluded volume
and hydrophobic and electrostatic interactions, this assump-
tion may not be justified. If so, the reaction order from fitting
kinetic data may be simply empirical and ultimately unre-
lated to the stoichiometry of the underlying reaction; in other
words, a reaction order of 1 does not necessarily imply a stoi-
chiometric coefficient of 1, and vice versa. A simple example
suffices to illustrate this difficulty. We consider only mono-
mer addition to preexisting fibrils. If this is an elementary
step, then
M þ Fx/k2 Fxþ 1
d½M
dt
¼ k2½M½F:
A plot of the initial rate of monomer loss, d[M]/dt, versus
[M]0 would be linear, and one would conclude that fibril
growth is via monomer addition. However, if monomer addi-
tion actually occurs by a two-step mechanism such as the
‘‘dock-lock’’ mechanism (44), where F* represents a fibril
where the monomer has docked but not yet locked into place,
then the reaction sequence is:
M þ Fx/k1)
k1
Fxþ 1
Fxþ1/
k2
Fxþ1:
Assuming that F* is a reactive intermediate, applying
the quasi-steady state assumption, and letting ½Ftot ¼P ½Fx  þP ½Fx, we find that P ½Fx  ¼ k1½M ½Ftotk1þk2þk1½M
i
and the rate of monomer loss isBiophysical Journal 96(7) 2871–2887d½M
dt
¼ k1½M½Ftot

1  ðk1  k1½MÞðk1 þ k2 þ k1½MÞ

:
Although the overall reaction is still monomer addition, and
the stoichiometry remains the same, the plot of initial rate of
monomer loss versus [M]0 is no longer linear. Such effects, if
present, further complicate the problem of extracting the
aggregation mechanism from kinetic data.
Our results clearly demonstrate the need for more compre-
hensive kinetic data on protein aggregation, including data
that extend over the full timescale of aggregation and
comprise multiple measures of aggregate size, structure,
and mass. In addition, mechanistic interpretations of kinetic
data require clear analysis of the reliability of estimated
parameter values and, of more importance, careful statis-
tics-based comparison of several alternative models. The crit-
ical importance of distinguishing among various aggregation
mechanisms becomes clear as one considers, for example, the
possible role of soluble oligomers in cellular toxicity or the
design of chemical ligands to prevent aggregation.
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